Profile
STVN ISRG BDXA BDX ALC RMD
Company Name Stevanato Group S.p.A. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $6.81B $183.74B $53.11B $49.57B $44.11B $40.72B
Employees 5.52K 15.64K 0.00K 70.00K 25.60K 9.98K
CEO Franco Stevanato Gary S. Guthart - Thomas E. Polen Jr. David J. Endicott Michael J. Farrell BE, MBA, SM
Ratings
STVN ISRG BDXA BDX ALC RMD
Quant Rating Score 2 3 5 3 3 4
Quant Rating Sell Neutral Strong Buy Neutral Neutral Buy
Trading
STVN ISRG BDXA BDX ALC RMD
Last Close $25.12 $483.12 $59.24 $176.37 $87.87 $279.2
High 52 $27.95 $610.45 $59.24 $249.08 $100.76 $279.2
Low 52 $17.27 $438 $59.24 $165.15 $82.73 $204.58
Price vs. 52 Week High -10.13 % -20.86 % 0 % -29.19 % -12.79 % 0 %
Price vs. 52 Week Low 45.45 % 10.3 % 0 % 6.79 % 6.21 % 36.47 %
Total Return
STVN ISRG BDXA BDX ALC RMD
1 Month Return 2.61 % -10.65 % 0 % -0.51 % -1.6 % 9.09 %
3 Month Return 17.49 % -8.75 % 0 % 4.5 % -10.61 % 16.36 %
6 Month Return 12.09 % -15.52 % 0 % -28.77 % -3.53 % 18.21 %
9 Month Return 28.23 % -4.59 % 0 % -25.03 % -4.27 % 14.3 %
YTD Return 15.28 % -7.44 % 0 % -22.26 % 3.51 % 22.09 %
1 Year Return 30.77 % 7.42 % 0 % -27.08 % -4.88 % 24.84 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
STVN ISRG BDXA BDX ALC RMD
Dividend Yield Percentage (TTM) 0.24 % - 2.28 % 2.35 % 0.37 % 0.76 %
Dividend Paid and Capex Coverage Ration (TTM) 0.61 % 2.77 % 1.77 % 1.77 % 3.43 % 4.21 %
Dividend Per Share (TTM) 0.06 % - 4.07 % 4.07 % 0.33 % 2.12 %
Payout Ratio (TTM) 11.52 % - 76.77 % 76.77 % 11.23 % 23.14 %
Growth
STVN ISRG BDXA BDX ALC RMD
Asset Growth 12.42 % 21.38 % 8.54 % 8.54 % 1.79 %
Gross Profit Growth -11.05 % 19.13 % 11.69 % 11.69 % 12.72 %
Revenue Growth 1.72 % 17.24 % 4.16 % 4.16 % 10.95 %
Revenue 3 Year 26.91 % 46.64 % -0.51 % -0.51 % 44.86 %
Revenue 5 Year 99.61 % 81.77 % 8.72 % 8.72 % 74.97 %
Revenue 10 Year - 266.32 % 59.37 % 59.37 % 189.94 %
EBIT Growth -13.78 % 32.95 % 19.82 % 19.82 % 12.75 %
Net Income Growth -19.13 % 29.18 % 14.89 % 14.89 % 13.75 %
Net Income 3 Yeari Growth Per Share -14.94 % 36.6 % -18.63 % -18.63 % 112.66 %
Net Income 5 Yeari Growth Per Share 191.45 % 64.12 % 30.19 % 30.19 % 145.63 %
Net Income 10 Yeari Growth Per Share - 418.52 % -4.02 % -4.02 % 184.54 %
Operating Income Growth -19.72 % 32.95 % 13.55 % 13.55 % 16.61 %
Operating Cash Flow Growth (CFG) 48.06 % 33.15 % 27.07 % 27.07 % 102.11 %
Operating 3 Year CFG 13.36 % 15.88 % -18.4 % -18.4 % 87.99 %
Operating 5 Year CFG 254.96 % 47.28 % 6.25 % 6.25 % 197.13 %
Operating 10 Year CFG - 239.49 % 45.28 % 45.28 % 244.62 %
EPS Growth -21.82 % 27.71 % 18.31 % 18.31 % 13.4 %
EPS Diluted Growth -21.82 % 27.63 % 18.62 % 18.62 % 13.63 %
Book Value Per Share 20.39 % 21.99 % -0.85 % -0.85 % 17.57 %
Share Holder 3 Year Equity Growth Per Share 61.85 % 37.85 % 9.16 % 9.16 % 66.6 %
Share Holder 5 Year Equity Growth Per Share 413.12 % 93.34 % 13.89 % 13.89 % 128.49 %
Share Holder 10 Year Equity Growth Per Share - 354.67 % 241.78 % 241.78 % 166.2 %
Dividend Per Share Growth -1.79 % - -2.44 % -2.44 % 9.12 %
Dividend 3 Year Growth Per Share 20.41 % - 4.79 % 4.79 % 23.08 %
Dividend 5 Year Growth Per Share 127.96 % - 4.14 % 4.14 % 29.8 %
Dividend 10 Year Growth Per Share - - 74.3 % 74.3 % 91.97 %
Debt Growth 8.16 % - 26.65 % 26.65 % -44.68 %
Free Cash Flow Growth 53.14 % 73.93 % 45.25 % 45.25 % 130 %
Updated On 31 Dec 2024 31 Dec 2024 30 Sep 2024 30 Sep 2024 30 Jun 2024
Profitability
STVN ISRG BDXA BDX ALC RMD
Gross Profit Margin TTM 27.2 % 67.09 % 44.5 % 44.5 % 55.55 % 58.53 %
Return on Assets TTM 5.4 % 12.88 % 2.75 % 2.75 % 3.61 % 17.36 %
Return on Equity TTM 9.18 % 15.52 % 5.86 % 5.86 % 5.22 % 25.18 %
Return on Capital Employed TTM 9.16 % 13.9 % 5.05 % 5.05 % 5.26 % 24.33 %
Net Income Per EBT TTM 73.87 % 88.31 % 89.01 % 89.01 % 83.9 % 83.26 %
EBT Per Ebit TTM 99.64 % 114.09 % 71.19 % 71.19 % 88.24 % 97.84 %
EBIT Per Revenue TTM 15.16 % 28.2 % 11.33 % 11.33 % 15.24 % 32.1 %
Cash Flow To Debt Ratio TTM 46.78 % - 17.12 % 17.12 % 40.46 % 196.83 %
Receivables Turnover TTM 2.31 6.46 6.89 6.89 5.34 5.53
Payables Turnover TTM 3.54 10.39 - - 5.24 9.36
Inventory Turnover TTM 3.13 1.85 3.11 3.11 1.88 2.41
Fixed Asset Turnover TTM 87.64 % 181.6 % 313.98 % 313.98 % 202.43 % 729.93 %
Asset Turnover TTM 48.39 % 45.34 % 38.31 % 38.31 % 32.01 % 66.36 %
Operating Cash Flow Per Share TTM 0.67 7.64 11.44 11.44 4.24 11.27
Free Cash Flow Per Share TTM -0.36 4.88 8.98 8.98 3.26 10.66
Cash Per Share TTM 33.24 % 1261.9 % 236.81 % 236.81 % 285.19 % 635.71 %
Operating Cash Flow Sales Ratio TTM 16.36 % 31.34 % 15.81 % 15.81 % 21.17 % 32.92 %
Free Cash Flow Operating Cash Flow Ratio TTM -53.59 % 63.9 % 78.51 % 78.51 % 76.82 % 94.64 %
Cash Flow Coverage Ratios TTM 46.78 % - 17.12 % 17.12 % 40.46 % 196.83 %
Price To Free Cash Flows Ratio TTM -60.32 105.28 19.72 19.14 27.32 26.03
Price To Operating Cash Flows Ratio TTM 32.33 67.1 15.58 15.12 21.01 24.65
Price Cash Flow Ratio TTM 32.33 67.1 15.58 15.12 21.01 24.65
Income Statement (TTM)
STVN ISRG BDXA BDX ALC RMD
Revenue $1.1B $8.35B $20.18B $20.18B $9.91B $5.15B
Gross Profit $0.3B $5.63B $9.13B $9.13B $5.51B $3.05B
Gross Profit Ratio 27.38% 67.46% 45.22% 45.22% 55.61% 59.36%
EBITDA $0.25B $2.81B $4.82B $4.82B $2.68B $1.69B
Net Income $0.12B $2.32B $1.71B $1.71B $1.02B $1.4B
EPS Diluted 0.43 6.42 5.86 5.86 2.05 -
Balance Sheet (MRQ)
STVN ISRG BDXA BDX ALC RMD
Long Term Debt $0.32B $0.11B $17.94B $17.94B $4.97B $0.84B
Total Liabilities $0.92B $2.31B $31.4B $31.4B $8.79B $2.01B
Total Equity $1.4B $16.53B $25.89B $25.89B $21.55B $4.86B
Total Investments $0.01B $7.05B $0.45B $0.45B $0.91B $0.17B
Total Debt $0.43B $0.15B $20.11B $20.11B $5.14B $0.87B
Total Assets $2.33B $18.84B $57.29B $57.29B $30.35B $6.87B
Cash Flow Statement (TTM)
STVN ISRG BDXA BDX ALC RMD
Net Income $0.16B $2.34B $1.71B $1.71B $1.02B $1.4B
Inventory $0.01B $-0.83B $0.1B $0.1B $-0.05B $-0.08B
Dividends Paid $-0.01B $0B $-1.1B $-1.1B $-0.13B $-0.31B
Operating Cash Flow $0.16B $2.42B $3.8B $3.8B $2.08B $1.75B
Capital Expenditure $-0.31B $-1.11B $-0.73B $-0.73B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 87.87
ANGO AngioDynamics, Inc. 8.56
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 141.35
ATRC AtriCure, Inc. 34.41
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 32.34
BAX Baxter International Inc. 21.96
BDX Becton, Dickinson and Company 176.37
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 13.5
BLFS BioLife Solutions, Inc. 20.805
COO The Cooper Companies, Inc. 70.87
DXR Daxor Corporation 9.45
EKSO Ekso Bionics Holdings, Inc. 3.49
FEMY Femasys Inc. 0.8196
ETFs With Exposure to STVN
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.13939 133.04
FPXI First Trust International Equity Opportunities ETF 0.58 54.0128
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.32 30.8575
VINEX Vanguard International Explorer Fund Investor Shares 0.08 19.52
KOMP SPDR S&P Kensho New Economies Composite ETF 0.252588 54.73
BOUT Innovator IBD Breakout Opportunities ETF 2.98 36.58
BKIE BNY Mellon International Equity ETF 0 83.41
GSID Goldman Sachs MarketBeta International Equity ETF 0 62.56
GSUS Goldman Sachs MarketBeta US Equity ETF 0 86.06
VGHAX Vanguard Health Care Fund Admiral Shares 0.06 71.91
VGHCX Vanguard Health Care Fund Investor Shares 0.06 170.52
SENT AdvisorShares Alpha DNA Equity Sentiment ETF 1 21.2172
IGDA.L Invesco Markets II plc - Invesco Dow Jones Islamic Global Developed Markets UCITS ETF 0.0024 30.865
LETB AdvisorShares Let Bob AI Powered Momentum ETF 1.25 22.835
GDOC Goldman Sachs Future Health Care Equity ETF 0 30.69
VEXPX Vanguard Explorer Fd 0.04482 112.51
VEXRX Vanguard Explorer Fund 0.29 104.65
GXUS Goldman Sachs ETF Trust II - Goldman Sachs MarketBeta Total International Equity ETF 0 50.2633
Unlock